000 01358 a2200421 4500
005 20250516050540.0
264 0 _c20120516
008 201205s 0 0 eng d
022 _a1545-5017
024 7 _a10.1002/pbc.23275
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOrgel, Etan
245 0 0 _aHearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.
_h[electronic resource]
260 _bPediatric blood & cancer
_cJun 2012
300 _a953-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCarboplatin
_xadverse effects
650 0 4 _aChild, Preschool
650 0 4 _aCisplatin
_xadverse effects
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aHearing Loss
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aRetrospective Studies
650 0 4 _aSurvivors
700 1 _aJain, Shveta
700 1 _aJi, Lingyun
700 1 _aPollick, Liora
700 1 _aSi, Stephanie
700 1 _aFinlay, Jonathan
700 1 _aFreyer, David R
773 0 _tPediatric blood & cancer
_gvol. 58
_gno. 6
_gp. 953-8
856 4 0 _uhttps://doi.org/10.1002/pbc.23275
_zAvailable from publisher's website
999 _c21042729
_d21042729